Conversion to enteric-coated mycophenolate sodium from mycophenolate mofetil in stable renal transplant patients: Results of an Asia–Pacific study (pages 57–62)
Po-Huang Lee, Anantharaman Vathsala, Duck Jong Han, Tak-Mao Chan, Hin-Seng Wong, Chad Woodcock, Nicol Kurstjens, on behalf of the Asia Pacific MyPROMS Study Investigators, Pary Sivaraman, Sheng-Hsien Chu, Hwei-Ho Hsieh, Kuo-Hsiung Hsu, Po-Chang Lee, Jong-Da Lian, Wu-Chang Yang, Zaki Morad, Si-Yen Tan, Duck Jong Han, Ki Il Park, Yui-Pong Siu and Wai Kay Tsang
Version of Record online: 17 DEC 2012 | DOI: 10.1111/nep.12007
This study enrolled 112 patients from 16 Asian centres in Asian countries demonstrating that enteric-coated mycophenolate sodium is a safe and effective alternative to mycophenolate mofetil. The incidence of gastrointestinal upset was reduced.